{"name":"Minoxidil","slug":"minoxidil","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Loniten","Rogaine","Minoximen","Theroxidil","Alopexil","Alostil","Tricoxidil","Lonolox","Regaine","Normoxidil"],"brands":[],"scraped":true,"has_structure":true,"cid":4201,"classes":[{"name":"calcium channel blocker","href":"/class/calcium_channel_blocker"}],"families":[{"name":"piperidine","href":"/substituted/piperidine"}],"physical":[{"label":"Molecular mass","value":"209.25 g/mol","copyable":false},{"label":"Melting point","value":"248 °C","copyable":false},{"label":"Solubility","value":"2200 mg/L","copyable":false},{"label":"Predicted LogP","value":"1.2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>9</sub>H<sub>15</sub>N<sub>5</sub>O","copyable":true},{"label":"IUPAC name","value":"3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine","copyable":true},{"label":"SMILES","value":"C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O","copyable":true},{"label":"InChI","value":"InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2","copyable":true},{"label":"InChIKey","value":"ZIMGGGWCDYVHOY-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"38304-91-5","copyable":true},{"label":"UNII","value":"5965120SH1","copyable":true},{"label":"PubChem CID","value":"4201","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"Oral: 30–60 minutes (peak), Sublingual: 30 minutes","copyable":false},{"label":"Elimination half-life","value":"Oral: 3–4 hours, Topical: 22 hours<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Duration of action","value":"Oral: ~72 hours, Topical: 10–12 hours","copyable":false},{"label":"Metabolism","value":"Primarily liver via glucuronidation, hydroxylation, and sulfation (SULT1A1, SULT2A1)","copyable":false},{"label":"Excretion","value":"Urine: &gt;97% (10–15% unchanged; within 12–20 hours for oral and 4 days for topical)","copyable":false},{"label":"Routes of administration","value":"Oral, sublingual, topical (solution, foam, spray)","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Minoxidil tartrate","name":"tartrate","slug":"minoxidil_tartrate","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"D11AX01","description":""}],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"ABCC8","mechanisms":["shared target"],"partners":1,"contraindicated":0},{"target":"KCNJ11","mechanisms":["shared target"],"partners":1,"contraindicated":0}],"mechanism":"Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl<sup>-</sup>2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles.","side_effects":{"drug_id":4201,"drug_name":"minoxidil","url":"https://sideeffects.embl.de/drugs/4201/pt","atc_codes":["C02DC01","D11AX01"],"side_effects":[{"name":"Angina pectoris","cui":"C0002962"},{"name":"Breast disorder","cui":"C0006145"},{"name":"Cardiac tamponade","cui":"C0007177"},{"name":"Oedema","cui":"C0013604"},{"name":"Toxic epidermal necrolysis","cui":"C0014518"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Cardiac disorder","cui":"C0018799"},{"name":"Hypertrichosis","cui":"C0020555"},{"name":"Hypotension","cui":"C0020649"},{"name":"Leukopenia","cui":"C0023530"},{"name":"Mediastinal disorder","cui":"C0025061"},{"name":"Nausea","cui":"C0027497"},{"name":"Pericardial effusion","cui":"C0031039"},{"name":"Pericarditis","cui":"C0031046"},{"name":"Pleural effusion","cui":"C0032227"},{"name":"Erythema multiforme","cui":"C0014742"},{"name":"Stevens-Johnson syndrome","cui":"C0038325"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Thrombocytopenia","cui":"C0040034"},{"name":"Virilism","cui":"C0042755"},{"name":"Vomiting","cui":"C0042963"},{"name":"Weight increased","cui":"C0043094"},{"name":"Oedema peripheral","cui":"C0085649"},{"name":"Dermatitis bullous","cui":"C0085932"},{"name":"Bullous eruption","cui":"C0235818"},{"name":"Blood alkaline phosphatase increased","cui":"C0852911"},{"name":"Malnutrition","cui":"C0162429"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Hair growth abnormal","cui":"C0232409"},{"name":"Breast tenderness","cui":"C0262397"},{"name":"Fluid retention","cui":"C0268000"},{"name":"Water retention","cui":"C0542203"},{"name":"Electrocardiogram ST segment","cui":"C0429029"},{"name":"Hair colour changes","cui":"C0474378"},{"name":"Electrocardiogram abnormal","cui":"C0522055"},{"name":"Blood creatinine increased","cui":"C0235431"}],"indications":[{"name":"Cardiac output increased","cui":"C0085128"},{"name":"Encephalopathy","cui":"C0085584"},{"name":"Hypertension","cui":"C0020538"},{"name":"Refractory hypertension","cui":"C0860493"},{"name":"Retinal disorder","cui":"C0035309"},{"name":"Vascular resistance systemic","cui":"C1258192"},{"name":"Water retention","cui":"C0542203"}]},"effects":null,"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Minoxidil","composite":false,"routes":[{"name":"Transdermal","dosage":null,"onset":null,"comeup":null,"duration":null,"active":null},{"name":"Oral","dosage":"10-15mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":["{wkp 'hair loss'}"],"effects":["significantly reduced hairloss combined with {sub 'dutasteride'}","{sev 'intense'} {xeff 'vasodilation'}","{sev 'intense'} {xeff 'respiratory depression'}"],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["seams to promote hair-regrowth"]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"S4 / S2","act":null,"refs":[4,5]},{"jurisdiction":"United Kingdom","status":"GSL / Prescription only","act":null,"refs":[6,7,8]},{"jurisdiction":"United States","status":"Topical OTC / Oral Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Minoxidil"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4201"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q106010438"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00350"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL802"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A6942"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=38304-91-5"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D00418"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9040685"},{"source":"Probes & Drugs","url":"https://www.probes-drugs.org/compound/PD003089"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Minoxidil"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/5965120SH1"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4201/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4201, Minoxidil. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/4201>https://pubchem.ncbi.nlm.nih.gov/compound/4201</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Minoxidil. UNII: 5965120SH1. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5965120SH1>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/5965120SH1</a>","Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. The Journal of Dermatological Treatment. June 2022; 33(4):1896–1906. PMID 34159872. <a href='https://doi.org/10.1080/09546634.2021.1945527'>https://doi.org/10.1080/09546634.2021.1945527</a>","59445 WOMEN&#39;S REGAINE EXTRA STRENGTH Minoxidil 5% application bottle. Therapeutic Goods Administration (TGA) / Australian Government Department of Health and Aged Care. <a href='https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&amp;docid=59445&amp;agid=%28PrintDetailsPublic%29&amp;actionid=1'>https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&amp;docid=59445&amp;agid=%28PrintDetailsPublic%29&amp;actionid=1</a>","Search the TGA website. Tga-search.clients.funnelback.com. <a href='https://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&amp;profile=record&amp;meta_i=79914'>https://tga-search.clients.funnelback.com/s/search.html?collection=tga-artg&amp;profile=record&amp;meta_i=79914</a>","Loniten Tablets 5mg - Summary of Product Characteristics (SmPC). Medicines.org.uk. November 24, 2020. <a href='https://www.medicines.org.uk/emc/product/4296/smpc'>https://www.medicines.org.uk/emc/product/4296/smpc</a>","Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam (GSL) - Summary of Product Characteristics (SmPC). (emc). April 27, 2021. <a href='https://www.medicines.org.uk/emc/product/5781/smpc'>https://www.medicines.org.uk/emc/product/5781/smpc</a>","Regaine for Women Once a Day Scalp Foam 5% w/w Cutaneous Foam - Summary of Product Characteristics (SmPC). Medicines.org.uk. October 28, 2020. <a href='https://www.medicines.org.uk/emc/product/5082/smpc'>https://www.medicines.org.uk/emc/product/5082/smpc</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 10:20:29","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 10:20:25","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 10:20:25","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 10:20:26","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 10:20:25","note":"no HMDB id"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 10:20:27","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 10:20:25","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 10:20:25","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 10:20:25","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 10:20:25","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 10:20:25","note":null}],"description":"Minoxidil is a calcium channel blocker substance."}